Postdoctoral Fellow - Novel Oligonucleotide-based strategies for Cancer Immunotherapy
Job posting number: #7100398 (Ref:10016736)
Posted: May 19, 2022
Application Deadline: Open Until Filled
About City of Hope
City of Hope is an independent biomedical research and treatment organization for cancer, diabetes and other life-threatening diseases.
Founded in 1913, City of Hope is a leader in bone marrow transplantation and immunotherapy such as CAR T cell therapy. City of Hope’s translational research and personalized treatment protocols advance care throughout the world. Human synthetic insulin, monoclonal antibodies and numerous breakthrough cancer drugs are based on technology developed at the institution. AccessHope™, a subsidiary launched in 2019 serves employers and their health care partners by providing access to City of Hope’s specialized cancer expertise.
A National Cancer Institute-designated comprehensive cancer center and a founding member of the National Comprehensive Cancer Network, City of Hope is ranked among the nation’s “Best Hospitals” in cancer by U.S. News & World Report and received Magnet Recognition from the American Nurses Credentialing Center. Its main campus is located near Los Angeles, with additional locations throughout Southern California and in Arizona.
City of Hope’s commitment to Diversity, Equity and Inclusion
We believe diversity, equity and inclusion is key in serving our mission to provide compassionate patient care, drive innovative discovery, and advance vital education focused on eliminating cancer and diabetes in all of our communities. Our commitment to Diversity, Equity and Inclusion ensures we bring the full range of skills, perspectives, cultural backgrounds and experiences to our work -- and that our teams align with the people we serve in order to build trust and understanding. We are dedicated to fostering a community that embraces diversity - in ideas, backgrounds and perspectives; this is reflected in our work and represented in our people.
The Postdoctoral Fellow position is available immediately in the Department of Immuno-Oncology at Beckman Research Institute in City of Hope Comprehensive Cancer Center, to develop novel, oligonucleotide-based immunotherapeutic strategies. We seek applications from candidates with expertise in oligonucleotide design, modification and testing, cancer immunotherapy or tumor immunology, and with strong interests in translational research in animal models of human malignancies. The environment of Beckman Research Institute is highly collaborative and these projects will involve multiple collaboration within the Brain Tumor Program at City of Hope and core laboratories across our Institution.
The ideal candidate will be able to work independently on molecular and cellular mechanisms of immunosuppression in humanized and syngeneic mouse tumor models utilizing the original oligonucleotide-based approaches. Skills in oligonucleotide studies, multicolor flow cytometry and/or animal studies are an advantage. They will be responsible for drafting manuscripts, progress reports and presenting the results internally as well as extramurally when needed. Highly motivated individuals with strong communication skills and ability to work in high paced, multidisciplinary environment are invited to apply.
Basic education, experience and skills required for consideration:
- PhD degree with research experience in the fields of immunology and cancer biology; a publication record in peer-reviewed scientific journals.
- Effectively design/develop a project in a translational research environment in order to successfully meet project goals.
- Design and execute laboratory experiments, critically interpret experimental results, and present data in a clear and concise manner.
- Participate in the preparation of grant applications, research publications, and attend/present at national conferences.
- Excellent oral and written communication skills.
- For more information on Dr. Marcin Kortylewski’s research, please visit here.
- As a condition of employment, City of Hope requires staff to comply with all state and federal vaccination mandates.
City of Hope is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, religion, color, national origin, sex, sexual orientation, gender identity, age, status as a protected veteran, or status as a qualified individual with disability.
City of Hope is a community of people characterized by our diversity of thought, background and approach, but tied together by our commitment to care for and cure those with cancer and other life-threatening diseases. The innovation that our diversity produces in the areas of research, treatment, philanthropy and education has made us national leaders in this fight. Our unique and diverse workforce provides us the ability to understand our patients' needs, deliver compassionate care and continue the quest for a cure for life-threatening diseases. At City of Hope, diversity and inclusion is a core value at the heart of our mission. We strive to create an inclusive workplace environment that engages all of our employees and provides them with opportunities to develop and grow, both personally and professionally. Each day brings an opportunity to strengthen our work, leverage our different perspectives and improve our patients’ experiences by learning from others. Diversity and inclusion is about much more than policies and campaigns. It is an integral part of who we are as an institution, how we operate and how we see our future.